Cargando…
Intraoperative radiotherapy for early breast cancer — insufficient evidence to change practice
We argue that the evidence remains insufficient for use of intraoperative radiotherapy (IORT) in women with early stage breast cancer outside of a clinical trial, as the recently reported TARGIT-A trial does not provide sufficient evidence to conclude that IORT is superior to no radiotherapy.
Autores principales: | Sasieni, Peter D., Sawyer, Elinor J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576112/ https://www.ncbi.nlm.nih.gov/pubmed/33087894 http://dx.doi.org/10.1038/s41571-020-00444-2 |
Ejemplares similares
-
Intraoperative radiotherapy for breast cancer: powerful evidence to change practice
por: Vaidya, Jayant S., et al.
Publicado: (2021) -
Early cancer detection by SERS spectroscopy and machine learning
por: Shi, Lingyan, et al.
Publicado: (2023) -
The tumor cell‐derived matrix of lobular breast cancer: a new vulnerability
por: Kozma, Katelyn J, et al.
Publicado: (2021) -
Is There a Role for Base Excision Repair in Estrogen/Estrogen Receptor-Driven Breast Cancers?
por: Abdel-Fatah, Tarek M.A., et al.
Publicado: (2014) -
Alteration of tumor suppressors changes the endometrial tumor spectrum
por: Mayo, Lindsey D
Publicado: (2023)